Resync is a Provider Activation Platform that automates patient identification by leveraging electronic health record (EHR) data to pre-screen eligible participants for clinical trials. This technology reduces the burden on trial sites and providers, minimizing screening failures and improving enrollment accuracy.
Funding
$2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Clinical trial enrollment is often hindered by the time-consuming and manual process of identifying eligible patients from electronic health records (EHRs). This burden on trial sites and providers leads to screening failures and inaccurate enrollment predictions.
Solution
Resync is a Provider Activation Platform designed to automate patient identification for clinical trials. By leveraging EHR data, the platform pre-screens patients to determine their eligibility, reducing the workload on trial sites and providers. This automated process minimizes screening failures and improves the accuracy of enrollment projections, enabling more efficient trial execution. The platform facilitates the creation and management of referral networks, streamlining the connection between providers and trial sites.
Target Audience
The primary target audience includes clinical trial sites and providers seeking to streamline patient enrollment, reduce screening failures, and improve the accuracy of enrollment predictions.
Features
- Automated pre-screening of patients based on EHR data
- Reduction of screening failures through efficient patient identification
- Improved accuracy in enrollment predictions for clinical trials
- Streamlined referral network management for providers and trial sites
- Rapid Feasibility Tool (Coming Soon) to showcase unique patient populations